Publication | Closed Access

Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia

Hematological MalignancyOncologyGemtuzumab OzogamicinElderly PatientsG-csf CombinationMedicineMixed-phenotype Acute LeukemiaHematologyPharmacotherapyPharmacologyMyeloid Neoplasia